Night-Shift Work Duration and Risk of Colorectal Cancer According to and Expression.
| Authors | |
| Abstract | BACKGROUND: We hypothesized that the risk of colorectal cancer in night-shift workers might be different according to insulin receptor substrate status. METHODS: Among 77,470 eligible women having night work assessed in the Nurses' Health Study, we documented a total of 1,397 colorectal cancer cases, of which 304 or 308 had available data on and , respectively. We used duplication-method Cox proportional hazards regression analysis for competing risks to calculate HRs and 95% confidence intervals (CI) for each colorectal cancer subtype. We measured tumor or expression by immunohistochemistry (IHC). RESULTS: Compared with women who never worked night shifts, those working ≥15 years night shifts had a marginal trend of increased overall risk of colorectal cancer ( = 0.06; multivariable HR = 1.20; 95% CI, 0.99-1.45). Longer duration of night-shift work was associated with a higher risk of -positive tumors (multivariable HR = 2.69; 95% CI, 1.48-4.89; = 0.001, ≥15 years night shifts vs. never) but not with -negative tumors (multivariable HR = 0.90; 95% CI, 0.54-1.51; = 0.72; for = 0.008). Similarly, the corresponding multivariable HRs were 1.81 for -positive tumors (95% CI, 0.94-3.48; = 0.06) and 1.13 for -negative tumors (95% CI, 0.71-1.80; = 0.56; for = 0.02). CONCLUSIONS: Our molecular pathologic epidemiology data suggest a potential role of in mediating carcinogenesis induced by night-shift work. IMPACT: Although these findings need validation, rotating night shift might increase colorectal cancer risk in women with abnormal insulin receptor pathways. |
| Year of Publication | 2020
|
| Journal | Cancer Epidemiol Biomarkers Prev
|
| Volume | 29
|
| Issue | 1
|
| Pages | 133-140
|
| Date Published | 2020 Jan
|
| ISSN | 1538-7755
|
| DOI | 10.1158/1055-9965.EPI-19-0325
|
| PubMed ID | 31666286
|
| PubMed Central ID | PMC6954315
|
| Links | |
| Grant list | R35 CA197735 / CA / NCI NIH HHS / United States
R01 CA151993 / CA / NCI NIH HHS / United States
R01 CA137178 / CA / NCI NIH HHS / United States
K24 DK098311 / DK / NIDDK NIH HHS / United States
K07 CA188126 / CA / NCI NIH HHS / United States
R03 CA176717 / CA / NCI NIH HHS / United States
P50 CA127003 / CA / NCI NIH HHS / United States
K07 CA190673 / CA / NCI NIH HHS / United States
R01 OH009803 / OH / NIOSH CDC HHS / United States
P01 CA087969 / CA / NCI NIH HHS / United States
|